CoChat
Sign Up
Cited by 82

The DOI matches its Crossref record.

Some biochemical properties of Russell’s viper (Daboia russelli) venom from Eastern India: correlation with clinico-pathological manifestation in Russell’s viper bite

Mukherjee, A.K., Ghosal, S.K., Maity, C.R.·2000·Toxicon
DOI 10.1016/s0041-0101(99)00125-7
Open this paper in CoChat — free account

Abstract

In the present study, some biochemical properties and pathological effects of Daboia russelli venom from Burdwan district of West Bengal, eastern India are presented. The clinical features of Russell's viper envenomation observed in patients admitted to Burdwan Medical College & Hospital are also reported. In vitro, whole venom exerts strong trypsin inhibitory, phospholipase A2 and procoagulant activities in addition to moderate adenosine monophosphatase and adenosine triphosphatase activities. Lethality (LD50) of this venom sample is 0.7 mg kg (i.v.) of mice. Significant local tissue damaging effects including edema, hemorrhage and necrosis are observed in experimental animal models. An increase in the level of serum enzymes, such as aspartate transaminase, alkaline phosphatase, creatine phosphokinase, lactate dehydrogenase after D. russelli venom injection in albino rats is indicative of cell or tissue damage. High incidence of intravascular hemolysis in addition to hemostasis, haemoptysis and haematuria are observed as the most prominent features of RVV envenomation from this part of India. The present study reinforces the hypothesis that variation in the venom composition of RVV from eastern India with respect to venom samples of Russell's vipers from other parts of India is responsible for the differences in the clinical manifestation in patients from eastern India.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0041-0101(99)00125-7

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 38

  1. Aye-Kyaw, 1994, Purification, characterization and biological activities of phospholipase A from Russell’s viper (Vipera russelli) venom, Int. J. Biochem., 26, 79, 10.1016/0020-711X(94)90199-6 · DOI
  2. Bhat, 1989, Purification and characterization of myotoxic phospholipase A2 from Indian cobra (Naja naja naja) venom, Toxicon, 29, 861, 10.1016/0041-0101(89)90098-6 · DOI
  3. Bjarnason, 1988, Hemorrhagic toxins from snake venom, J. Toxicol. Toxin Rev., 7, 121, 10.3109/15569548809059729 · DOI
  4. Campbell, 1962, Assay of 5′-nucleotidase activity, vol. 1, 918
  5. Chakraborty, 1991, Lethal and hemorrhagic activity of Russell’s viper venom-neutralization by polyvalent, monovalent and toxoid antiserum, Ind. J. Exp. Biol., 29, 456
  6. Chakraborty, 1993, Purification and partial characterization of hemorrhagin (VRH-I) from Vipera russelli venom, Toxicon, 31, 1601, 10.1016/0041-0101(93)90344-I · DOI
  7. Dubois, 1956, Colorimetric method of determination of sugars and related substances, Analyt. Chem., 28, 350, 10.1021/ac60111a017 · DOI · Paper page
  8. Furukawa, 1976, Purification and characterization of a coagulant protein from the venom of Russell’s viper, Biochem. Biophys. Acta, 453, 48
  9. Gene, 1985, Neutralization of hyaluronidase and indirect hemolytic activities of Costa Rican snake venom by a polyvalent antivenom, Toxicon, 23, 1015, 10.1016/0041-0101(85)90397-6 · DOI
  10. Gene, 1989, Comparative study on coagulant, defibrinating, fibrinolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom, Toxicon, 27, 841, 10.1016/0041-0101(89)90096-2 · DOI
  11. Hati, 1984, Snakebite in West Bengal of India, The Snake, 16, 129
  12. Hati, 1990, Active immunization of rabbits with gamma irradiated Russell’s viper venom toxoid, Toxicon, 28, 895, 10.1016/0041-0101(90)90019-4 · DOI
  13. Huang, 1984, Isolation and pharmacological properties of phospholipase A2 from Vipera russelli (Russell’s viper) snake venom, Toxicon, 22, 207, 10.1016/0041-0101(84)90021-7 · DOI
  14. Jayanthi, 1988, Geographical variation in India in the composition and lethal potency of Russell’s viper (Vipera russelli) venom, Toxicon, 26, 257, 10.1016/0041-0101(88)90216-4 · DOI
  15. Jeyarajah, 1984, Russell’s viper bite in Sir Lanka: A study of 22 cases, Am. J. Trop. Med. Hyg., 33, 506, 10.4269/ajtmh.1984.33.506 · DOI
  16. Kasturi, 1989, Purification and characterization of a major phospholipase A2 from Russell’s viper (Vipera russelli) venom, Toxicon, 27, 229, 10.1016/0041-0101(89)90136-0 · DOI
  17. Kini, 1982, Studies on snake venom enzymes. Part II—Partial characterization of ATPase from Russell’s viper (Vipera russelli) venom and their interaction with potassium gymnemate, Ind. J. Biochem. Biophys., 19, 342
  18. Larsen, 1968, The toxic proteins of cobra venom, Biochem-Pharmacol., 17, 503, 10.1016/0006-2952(68)90265-7 · DOI
  19. Lowry, 1951, Protein measurement with folin-phenol reagents, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 · DOI
  20. Maity, 1992, Study on the brain lipids of albino rats, The Snake, 24, 63
  21. Maung-Maung-Thwin, 1995, A major lethal factor of the venom of Burmese Russell’s viper (Daboia russelli siamensis): isolation, N-terminal sequencing and biological activities of daboiatoxin, Toxicon, 33, 63, 10.1016/0041-0101(94)00133-S · DOI
  22. Mittal, 1986, Renal lesions following viper bites—A study of 14 years, Ind. J. Med. Res., 83, 642
  23. Mukherjee, 1997, Lysosomal membrane stabilization by α-tocopherol against the damaging action of Vipera russelli venom phospholipase A2, Cell. Molec. Life Sci., 53, 152, 10.1007/PL00000586 · DOI
  24. Mukherjee, 1998, Effect of oral supplementation of vitamin E on the hemolysis and erythrocyte phospholipid splitting action of cobra and viper venoms, Toxicon, 36, 657, 10.1016/S0041-0101(97)00055-X · DOI
  25. Mukherjee, 1998, Composition of Naja naja venom samples from three districts of West Bengal, eastern India, Comp. Biochem. Physiol., 119, 621, 10.1016/S1095-6433(97)00475-3 · DOI
  26. Ouyang, 1976, Fibrinogenolytic enzymes of Trimeresurus mucrosquamatus venom, Biochim. Biophys. Acta, 420, 298, 10.1016/0005-2795(76)90321-4 · DOI
  27. Phillips, 1988, Paralysis, Rhabdomyolysis and hemolysis caused by bites of Russell’s viper (Vipera russelli pulchella) in Sri Lanka: failure of Indian (Haffkine) antivenom, Q. J. Med., 68, 691
  28. Sahu, 1989, Effects of envenomation on enzymes of brain of albino rats, Ind. J. Exp. Biol., 27, 831
  29. Sahu, 1991, Prospective study of some enyzmes in different parts of the rat’s brain following envenomation, The Snake, 23, 65
  30. Sharp, 1989, A basic phospholipase A from the venom of the Australian king brown snake (Pseudechis australis) showing diverse activities against membranes, Comp. Biochem. and Physiol., 92B, 501, 10.1016/0305-0491(89)90123-5 · DOI
  31. Soto, 1988, Proteolytic, hemorrhagic and hemolytic activities of snake venoms, Toxicon, 26, 875, 10.1016/0041-0101(88)90328-5 · DOI
  32. Than-Than, 1988, Haemostatic disturbances in patients bitten by Russell’s viper (Vipera russelli siamensis) in Burma, Br. J. Hematol., 69, 513, 10.1111/j.1365-2141.1988.tb02408.x · DOI
  33. Theakston, 1983, Development of simple standard assay procedures for the characterization of snake venoms, Bull. Wld. Hlth. Orag., 61, 949
  34. Tsai, 1996, Two types of Russell’s viper revealed by variation in phospholipase A2 from the venom of the subspecies, Toxicon, 34, 99, 10.1016/0041-0101(95)00114-X · DOI
  35. Tun-Pe, 1987, Acute and chronic pituitary failure resembling Sheehan’s syndrome following bites from Russell’s viper in Burma, Lancet, ii, 763, 10.1016/S0140-6736(87)92500-1 · DOI
  36. Vishwanath, 1988, Purification and partial biochemical characterization of an edema-inducing phospholipase A2 from Vipera russelli snake venom, Toxicon, 26, 713, 10.1016/0041-0101(88)90278-4 · DOI
  37. Warrell, 1989, Snake venom in science and clinical medicine. 1. Russell’s viper: biology, venom and treatment of bites, Trans. Roy. Soc. Trop. Med. Hyg., 83, 732, 10.1016/0035-9203(89)90311-8 · DOI
  38. Williams, 1962, The fractionation of Russell’s viper (Vipera russelli) venom with special reference to coagulant protein, Biochem. J., 84, 52, 10.1042/bj0840052 · DOI

Cited by

Sorted by citations

Metadata

Authors
Mukherjee, A. K., Ghosal, S. K., & Maity, C. R.
Venue
Toxicon
Publisher
Elsevier BV
Published
2000-02
Volume
38
Issue
2
Pages
163-175
ISSN
0041-0101
DOI
10.1016/s0041-0101(99)00125-7
Cited by
82
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review